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Abstract
Background: Various structural and functional factors of foot function have been associated with high local plantar pressures.
The therapist focuses on these features which are thought to be responsible for plantar ulceration in patients with diabetes. Risk
assessment of the diabetic foot would be made easier if locally elevated plantar pressure could be indicated with a minimum set
of clinical measures.
Methods: Ninety three patients were evaluated through vascular, orthopaedic, neurological and radiological assessment. A
pressure platform was used to quantify the barefoot peak pressure for six forefoot regions: big toe (BT) and metatarsals one
(MT-1) to five (MT-5). Stepwise regression modelling was performed to determine which set of the clinical and radiological
measures explained most variability in local barefoot plantar peak pressure in each of the six forefoot regions. Comprehensive
models were computed with independent variables from the clinical and radiological measurements. The difference between the
actual plantar pressure and the predicted value was examined through Bland-Altman analysis.
Results: Forefoot pressures were significant higher in patients with neuropathy, compared to patients without neuropathy for
the whole forefoot, the MT-1 region and the MT-5 region (respectively 138 kPa, 173 kPa and 88 kPa higher: mean difference).
The clinical models explained up to 39 percent of the variance in local peak pressures. Callus formation and toe deformity were
identified as relevant clinical predictors for all forefoot regions. Regression models with radiological variables explained about
26 percent of the variance in local peak pressures. For most regions the combination of clinical and radiological variables resulted
in a higher explained variance. The Bland and Altman analysis showed a major discrepancy between the predicted and the actual
peak pressure values.
Conclusion: At best, clinical and radiological measurements could only explain about 34 percent of the variance in local
barefoot peak pressure in this population of diabetic patients. The prediction models constructed with linear regression are not
useful in clinical practice because of considerable underestimation of high plantar pressure values. Identification of elevated
plantar pressure without equipment for quantification of plantar pressure is inadequate. The use of quantitative plantar pressure
measurement for diabetic foot screening is therefore advocated.
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Introduction
Clinical examination is considered important in the eval-
uation of the diabetic foot. Physicians and foot care spe-
cialists should be able to identify patients at risk of
adverse outcomes such as ulceration. A structured clinical
assessment that incorporates diagnostic tests alongside a
thorough history and examination is thought to be essen-
tial for preventive strategies[1]. High plantar pressures
have been shown to be related to development of foot
ulcers in people with diabetes. However, no study has
assessed the relative importance of clinical examination in
relation to the prediction of peak pressure.
Various structural and functional factors of foot function
have been associated with high local plantar pressures
such as limited joint mobility [2-4], plantar soft tissue
thickness, stiffness and callosities [5-17], metatarsal
length [18-20], the configuration of the medial longitudi-
nal arch [21-24], the presence of metatarsal deformi-
ties[25,26] and toe deformities[27,28]. These features are
associated with locally elevated plantar pressure which
could cause plantar ulceration in patients with diabetes.
To decide whether a diabetic foot is at risk, foot care spe-
cialists make an inventory of these features through obser-
vation, physical examination and radiographic
evaluation. Risk assessment of the diabetic foot would be
made easier if locally elevated peak pressure could be indi-
cated with a minimum set of commonly used clinical
measures.
An alternative diagnostic screening method for abnormal
physical stress on the foot sole is direct quantitative meas-
urement of plantar pressure. In the last few decades elec-
tronic devices such as pressure sensitive platforms have
become commercially available for this purpose. This
equipment is relatively expensive and there is no reim-
bursement by health insurers of the costs for the provision
of this screening procedure. Consequently, this diagnostic
facility is seldom provided as standard care in clinical set-
tings.
The primary objective of this study was to assess the rela-
tionship between clinical measurements, radiological
data and barefoot plantar pressure in order to find clinical
measures that predict local peak pressure in patients with
diabetes. In addition, we also evaluated previously pro-
posed regression models by various authors with the same
and/or similar variables as those obtained in our current
study. To evaluate the effect of peripheral neuropathy as a
predictor in this study, we included both patients with –
and without peripheral neuropathy. The secondary objec-
tive of this study was to assess the differences in clinical
measurements, radiological data and barefoot peak pres-
sure between patients with – and without peripheral neu-
ropathy.
Methods
Patients
Diabetic patients were selected from the outpatient clinic
of the University Hospital Maastricht. Inclusion criteria
were diabetes mellitus type 1 (longer than 10 years after
date of diagnosis) or type 2 (at least one year after date of
diagnosis); age between 30 and 75 years and able to per-
form daily-life activities without supporting devices.
Exclusion criteria were a history of rheumatoid arthritis,
severe foot trauma, severe deformity i.e. which require
orthopaedic shoes and/or surgery of the foot.
Before the start of the study, patients were informed about
all study procedures and their possible risks. The Research
Ethical Committee of the University Hospital Maastricht
approved the study. One hundred and twenty five eligible
patients were screened for peripheral neuropathy through
determination of the vibration perception threshold
(VPT) at the apex of the hallux with a biothesiometer
(Biomedical, Newbury OH)[29,30]. A VPT higher than 25
Volts was used as the diagnostic criterion for peripheral
Table 1: Patient characteristics
PNP- PNP+
n 49 44
Gender (female/male) 30/19 29/15
Type of DM (1/2) 18/31 9/35
female male female male
Mean SD Range Mean SD Range Mean SD Range Mean SD Range
Age (yr) 56.3 9.1 35 50.9 9.5 38 64.9 8.8 26 58.8 10.4 44
Duration diabetes (yr) 13.8 10.2 36 11.6 7.7 31 18.1 11.4 38 16.3 11.4 42
HBa1c (percent) 8.31 1.5 4.8 8.15 1.1 46 8.25 1.3 5.5 8.16 1.3 6.3
BMI (kg/m2) 28.9 5.2 19.8 28.2 4.8 17.9 31.2 7.4 25.7 29.6 6.5 27.3
VPT = vibration perception threshold, PNP+ = peripheral polyneuropathy (VTP > 25 Volts), PNP- = no peripheral polyneuropathy (VPT ≤ 25 
Volts), DM = diabetes mellitus, HbA1c = hemoglobin A1c, yr = year, BMI = Body Mass IndexBMC Endocrine Disorders 2008, 8:16 http://www.biomedcentral.com/1472-6823/8/16
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neuropathy. Table 1 contains descriptive data with respect
to gender, age, body mass index (BMI), duration of diabe-
tes and glycosylated haemoglobin (HBa1c). Thirty two
patients were excluded because of corrupted plantar pres-
sure data due to technical failure. Finally, data of 93
patients were used for analysis. None of the subjects had
a history of foot ulceration.
Barefoot plantar pressure measurement
An EMED SF-4®  pressure sensitive platform (Novel,
Munich) was used to quantify the barefoot plantar pres-
sures of the patients' feet and was performed according to
a one-step protocol[31,32]. Barefoot peak pressure was
estimated per foot by calculating the mean over the read-
ings of 5 steps. This was done for the whole forefoot and
six separate forefoot regions: big toe and metatarsals one
(MT-1) to five (MT-5) through weight-bearing anterior-
posterior radiographs and Novel 'clinics®' software[33].
Prior to data collection the grade of callus formation
under the plantar aspect of the hallux and the metatarsals'
heads was scored according to the method described by
Colagiuri et al[17] (1995). The definitions of scores were:
grade 1) Distinct area with minimal thickening of keratin
layer, grade 2) moderate thickening of keratin layer, grade
3) marked thickening of keratin layer. The callus forma-
tion was not removed prior to the data collection, because
this was a factor of interest in the prediction of peak pres-
sure.
Peripheral neurological assessment
The 'Valk' scoring system[34] for clinical neurological
examination was performed to assess the grade of
polyneuropathy. Pinprick sense and light touch sense
(cotton wool) of the dorsum of the foot was tested on the
mid-foot and compared to the proximal quality of sensa-
tion of the ankle. The quality of the vibration sense was
tested with a 128 Hz tuning fork. The vibration sense of
the big toe was compared to the vibration sense of the
ankle, and the vibration sense of the ankle was compared
to the patella. The ankle reflex action was compared to the
knee reflex action. Pinprick sense, light touch sense, vibra-
tion sense of toes and ankles, and ankle reflexes were sep-
arately scored for both feet. Criteria for scoring for:
normal (0), impaired in comparison with proximal (1)
and absent (2), summing up to a maximum score of 20
points. Additionally, light touch sense was related to the
anatomical level below which it was impaired: no abnor-
malities (0), toe (1), mid-foot (2), ankle (3), mid-calf (4)
and knee (5). The outcome of the total score could vary
between 0 and 25. According to Valk et al (1997) a score
higher than 4 was graded as peripheral polyneuropa-
thy[35].
Orthopaedic assessment
The passive ankle joint dorsal flexion range of motion was
measured through use of a plastic goniometer with the
patient in prone position and the knee flexed[36]. The
range of dorsiflexion of the first metatarsophalangeal
joint relative to the first metatarsal shaft was measured in
a non-weight bearing position. The bisection lines of the
goniometer were placed along the medial shaft of the first
metatarsal and the proximal phalanx of the hallux. The
degree of hallux valgus was measured in accordance with
the guidelines of the American Academy of Orthopaedic
Surgeons[37].
The presence of claw toe, mallet toe, curly toe or hammer
toe deformity was scored according to the definitions
described by Myerson and Shereff[27]. These definitions
were used as references for classification of the degree of
toe deformity. Accordingly, toe alignment could be nor-
mal or deformed as defined by Myerson and Shereff: i.e.
'normal toe' was recorded if there was no deformity
present. In addition, less and more malalignment than the
definitions described by Myerson and Shereff was arbitrar-
ily classified as minor and severe.
From a dorsal view, a crude judgement of the resting cal-
caneal stance position was made through visual inspec-
tion while the patient was in standing at rest position. The
resting calcaneal stance position was recorded as neutral,
varus or valgus alignment. In addition, the medial arch
height was subjectively classified into: no arch (pes pla-
nus); lowered arch; normal arch; elevated arch and exces-
sively elevated arch.
Vascular assessment
For vascular tests, the patient lay supine and rested for at
least 15 minutes prior to testing. A standard examination
protocol for each lower extremity was performed. Resting
ankle-brachial index (ABI) was obtained through contin-
uous wave Doppler technique and performed at a 45
degree angle to the skin. Ankle-brachial index was calcu-
lated with the highest Doppler derived systolic pressure at
the ankle (dorsalis pedis or posterior tibialis artery),
indexed to the highest Doppler derived brachial artery
pressure.
A Hokanson CE-4 strain gauge and photoplethysmograph
was used to obtain toe pressure. A suitably sized cuff was
wrapped around the proximal phalanx of the hallux.
Once the best signal was acquired, the cuff was inflated
until the signal disappeared, after which the cuff was
slowly deflated until the signal reappeared (Application
note: 85315, Hokanson D. E., Inc. Bellevue; WA, USA.).
This was taken as the toe systolic pressure. Settings of
equipment for all vascular assessment procedures wereBMC Endocrine Disorders 2008, 8:16 http://www.biomedcentral.com/1472-6823/8/16
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standardized. All measurements were carried out by the
same experimenter. Each measurement was done three
times, with the mean used for analysis.
Radiographic evaluation
Measurements from standardized static weight-bearing
foot radiographs have been shown to be an objective and
reliable way of assessing both bony structure and soft tis-
sue dimensions [38-42]. Weight-bearing anterior-poste-
rior and lateral radiographs were taken with the subject
standing on a platform with the central beam for the lat-
eral view (55 kV, 8 mAs) directed horizontally at the
plantar aspect of the base of the first metatarsal and the
first cuneiform from a distance of 100 cm. For the ante-
rior-posterior view (55 kV, 12 mAs), the beam was
directed at the navicular from a distance of 150 cm. This
radiographic protocol was previously described by Cavan-
agh et al[43]. A radio-opaque marker was placed on the
radiographic plate in order to judge afterwards whether
scale correction was necessary.
All radiographs were taken by the same radiographer,
using the same equipment and settings. Measurements
were taken through line drawing and a protractor was
used to measure the angles. Nine angular and six linear
measurements were determined from the lateral radio-
graphs. Five angular and thirteen linear measurements
were determined from the anterior-posterior radiographs.
All measurements were taken by the same experimenter.
Statistical analysis
To meet assumptions of normality of statistical distribu-
tions peak plantar pressure scores were natural log trans-
formed. At first, data from 186 feet were used for analysis.
Repeated measures ANOVA showed no statistical signifi-
cant differences between left and right feet as a general
effect in the repeated measures model, nor specified for
the peak pressures scores (i.e. the interactions of peak
pressure with left or right side), nor specified for regional
peak pressure (i.e. the interactions of regional peak pres-
sure with left or right side). Therefore it was legitimate in
the eventual data analysis to average scores over left and
right sides.
Next, stepwise regression analysis modelling was per-
formed to determine which of the clinical or radiological
measures will explain how much of the variance in aver-
aged local barefoot plantar peak pressure, in each of the
six forefoot regions and the whole forefoot separately. At
first, all potential predictors of each subsets (clinical or
radiological) were entered into the regression model
through 'forward selection' and the resulting model with
predictors having only statistical significant effects were
noted. In the second step, all potential predictors are
entered simultaneously and 'backward elimination' was
applied until a model was found with predictors having
statistical significant effects only. Finally, a cross-section
of both resulting models was made using predictors hav-
ing statistically significant effects in both models and this
cross-section of predictors is 'force-entered' into the final
regression model[44,45]. Comprehensive models are
assembled from the significant effects of both clinical or
radiological predictors following the same three-step pro-
cedure. Previously found results from literature were com-
pared with results from our procedure. All regression
analysis models were performed using list wise deletion of
missing cases. To prevent type I error as much as possible
in the multiple use of regression analysis, a Bonferroni
correction was applied through the division by the
number of plantar regions. Therefore, an alpha level of
0.01 was chosen to judge statistical significance.
To evaluate the prediction models for each individual
patient the difference between the predicted value and the
actual value was plotted against their mean. This method
is also known as residual analysis. In the clinical literature
this method is recognized as Bland-Altman analysis,
which allows one to judge the agreement between two dif-
ferent measurement techniques[46]. Categorical data
were analysed with Chi-square statistics. All data were
analysed with SPSS 13.0® (SPSS Inc., Chicago, USA).
Results
Differences between feet with and without neuropathy
Plantar pressure
Forefoot pressures were significant higher in patients with
neuropathy, compared to patients without neuropathy for
the whole forefoot, the MT-1 region and the MT-5 region
(respectively 138 kPa, 173 kPa and 88 kPa higher: mean
difference), table 2.
Clinical measurements
There were no were statistically significant differences
between extremities with and without neuropathy with
respect to the ankle-brachial index, toe pressure and pas-
sive dorsal flexion range of the ankle joint (p-values ≥
.126).
The range of dorsal flexion motion of the MT-1 joint was
statistically significantly greater in feet without neuropa-
thy compared to neuropathic feet: 15 degrees. The hallux
valgus angle measured with a goniometer was statistically
significantly greater in diabetic feet: 5.3 degrees (table 3).
Callus formation and toe deformity
The distributions of callus formation and toe deformity
grades were similar for both feet with and without neu-
ropathy (figures 1 and 2). Most important callus forma-
tion was found under the hallux and the head of MT-1,BMC Endocrine Disorders 2008, 8:16 http://www.biomedcentral.com/1472-6823/8/16
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while the least callus formation was found under the lat-
eral side of the forefoot: MT-3 to MT-5.
For both groups the grade of toe deformity increased from
the first to the fifth toe. No statistically significant differ-
ences for callus formation and toe deformity were found
(p-values > .056), except that neuropathic feet had a
slightly higher grade of deformity of the 4th and 5th toe (p-
values < .042).
Calcaneal alignment
The proportions for classification of the calcaneal resting
position for feet with and without neuropathy was: 'neu-
tral' 47.2 percent versus 51.2 percent; 'valgus' 46.2 percent
versus 47.5 percent and 'varus' 6.6 percent versus 1.3 per-
cent, respectively.
Arch height
The proportions of arch height classification for patients
with and without neuropathy were: 'no arch' 6.6 percent
versus 13.8 percent; 'lowered arch' 42.5 percent versus 31.3
percent; 'normal arch' 17.9 percent versus 21.1 percent;
'elevated arch' 26.4 percent versus 32.5 percent and 'exces-
sively elevated arch' 6.6 percent versus 1.3 percent.
No statistically significant differences between neuro-
pathic feet and feet without neuropathy for both calcaneal
resting position and arch height were found (p > .062).
Radiographic evaluation
The statistically significant differences for patients with
neuropathy compared to patients without neuropathy
listed as radiographic measures in millimetres (mm) and
degrees (deg) were: MT-5 base height -0.6 mm, navicular
height -3.7 mm, inferior calcaneal inclination -2.9 deg,
Chopart's joint angle -1.4 deg, Lisfranc's joint angle +2.0
deg, MT-5 inclination -1.5 deg, MT-1 inclination -1.6 deg,
Talar inclination +3.0 deg, 1st PIP joint inclination -2.1
deg, hallux valgus +2.4 deg, MT-2 thickness +0.4 mm and
MT-3 thickness +0.4 mm (table 4).
Prediction of barefoot plantar peak pressure
Regression models
With a maximum of 5 predictors, the regression models
with clinically independent variables explained up to 34
percent of variance of local peak pressures (table 5). The
regression models with clinical variables explained more
variance for the medial forefoot and the hallux than for
the lateral forefoot. Callus formation was a relevant clini-
cal predictor for all regions and the 'Valk score' for two
regions and the whole forefoot. For the hallux region, the
best model with 24 percent of explained variance of peak
pressure was also achieved with clinical variables.
The regression model with radiological variables for the
forefoot peak pressure with 4 predictors explained 18 per-
cent of the variance of plantar pressure. The model for the
Table 2: Barefoot plantar peak pressure (kPa)
PNP- (106 feet) PNP+ (80 feet)
Mean SD Min- Max Mean SD Min- Max
**Whole forefoot 551 226 234–1218 689 279 288–1262
Big toe 455 264 81–1180 405 257 24–1070
**MT-1 308 138 90–801 481 313 132–1260
MT-2 475 226 160–1210 551 271 199–1220
MT-3 429 168 187–1120 462 202 152–1000
MT-4 288 102 140–660 311 149 125–1020
*MT-5 224 147 70–782 312 238 66–1060
PNP versus PNP + *p < 0.05 & **p < 0.005
Table 3: Clinical measurements
PNP- PNP+
Mean SD Min-Max Mean SD Min-Max
**Vibration Perception Threshold 13,78 5,05 4,8–25 43,55 8,82 25,2–50
**Valk score 2,1 3,1 0–15 12,9 7,3 0–24
Ankle-Arm index 1,06 0,19 0,52–1,83 1,08 0,28 0,63–2,3
Toe pressure 109,5 29,8 47,5–200 113,8 36,9 44–255
Dorsal flexion ankle joint 10 6,4 -5–25 9 6,9 -5–25
**Dorsal flexion motion MT-1 joint 93 16,8 45–150 78 16,0 40–110
**Hallux valgus angle 11,1 5,6 0–25 16,4 11,4 0–50
**PNP- versus PNP+ p < 0.005BMC Endocrine Disorders 2008, 8:16 http://www.biomedcentral.com/1472-6823/8/16
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MT-5 region explained no more than 22 percent of the
variance, which was the best result with radiological vari-
ables compared to the models for the other regions.
For most regions, the comprehensive model i.e. the com-
bination of clinical and radiological predictors, resulted in
the largest explained variance: 26% (forefoot), 34% (MT-
1 region), 25% (MT-2 region), 16% (MT-3 region), 13%
(MT-4 region) and 29% (MT-5 region), table 5.
Previously proposed regression models
We used the same radiological measures in the present
study as in previous studies by Morag and Cavanagh
(1999)[47]. The model for the hallux region, yielded an r
of .061 and an r2 of .004, SE 0.71 (overall p-value .877).
The models for the MT-1 region proposed by Cavanagh et
al (1997)[38], resulted in r .27, r2 .075, SE 0.51 (p = .007)
and Morag and Cavanagh (1999)[47], r .31, r2 .10, SE 0.51
(p = .002). The only statistically significant beta, also
known as beta weight or standardized regression coeffi-
cient, in the MT-1 model was 'sesamoid height', i.e. soft
tissue thickness under the first metatarsalphalangeal joint.
We also evaluated proposed regression models by Mueller
et al.(2003)[48], Ahroni et al. (1999)[49] and Payne et al.
(2002)[50] with similar variables from our dataset for the
plantar regions concerned. No statistically significant
regression models were found for the hallux region.
The models proposed by Mueller et al. for MT-1 (hallux
valgus angle, Morton's index, body weight) to MT-3
(hammer toe deformity, soft tissue stiffness, calcaneal
inclination) and MT-5 (hammer toe deformity, Morton's
index) were statistically significant: MT-1 region r .32, r2
.105 SE 0.50 (p = .001); MT-2 region r .32, r2 .103, SE 0.43
(p = .001); MT-3 region r .22, r2 .046, SE 0.38, (p = .013)
and MT-5 region R .29, r2 .072, SE 0.61 (p = .004). This
was also true for the model for prediction of plantar pres-
sure under the forefoot by Ahroni et al. (body weight,
insulin use) and the model for the MT-1 region suggested
by Payne et al. (MTP-1 range of motion, Michigan Neu-
ropathy Score): r .46, r2 .212, SE 0.19 (p = .001) and r .36,
r2 .131, SE 0.49 (p = .001), respectively.
Bland-Altman analysis
Figures 3 and 4 show the difference between the observed
and predicted peak pressure plotted against their mean for
the MT-1 region. Figure 3 shows the results based on the
comprehensive regression model and figure 4 shows the
results based on the regression model proposed by Cavan-
agh et al. (1997)[38]. Figures 3 and 4, mean values
between 200 kPa and 450 kPa, show both positive and
negative differences of circa 200 kPa, while the difference
between the observed and predicted peak pressure
increases at higher values.
The dotted lines in figures 3 and 4, indicate the 65 percent
range of differences (1 SD) and the range for 95 percent of
differences (2 SD).
Discussion
We explored new and previously suggested relationships
between clinical measurements, data from radiographs
and barefoot plantar pressure in patients with diabetes.
Proportions of callus formation score, as a percentage, for  patients with and without neuropathy Figure 1
Proportions of callus formation score, as a percent-
age, for patients with and without neuropathy. None 
= no thickening of keratin layer, Grade 1 = Distinct area with 
minimal thickening of keratin layer, Grade 2 = moderate 
thickening of keratin layer, Grade 3 = marked thickening of 
keratin layer. MT = metatarsal, PNP - = without neuropathy, 
PNP + = with neuropathy.
Proportions of toe deformity ratings, as a percentage, for  patients with and without neuropathy Figure 2
Proportions of toe deformity ratings, as a percent-
age, for patients with and without neuropathy. Nor-
mal = no malalignment whereas minor, significant and severe 
are respectively defined as less, the same or more deformed 
than the definitions described by Myerson and Shereff.BMC Endocrine Disorders 2008, 8:16 http://www.biomedcentral.com/1472-6823/8/16
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The primary aim of the present study was to find a mini-
mal combination of measures which could indicate loca-
tions with elevated plantar pressure as an alternative for
quantitative plantar measurement.
Results from clinical examination and radiographic 
evaluation
Consistent with what is reported in the literature, higher
peak pressures were measured under the neuropathic fore-
foot than those under the forefoot without neuropa-
thy[51]. The greatest difference was measured in the MT-1
region. The dorsal flexion motion of the metarsalphalan-
geal joint of the first toe was less while the hallux valgus
angle was greater in neuropathic feet compared to feet
without neuropathy. Both observations were previously
reported in the literature and are positively correlated with
plantar pressure[38,43,52,53].
The distributions of callus formation and toe deformity
grades were similar for feet with and without neuropathy.
Neuropathic feet had a slightly higher grade of deformity
of the 4th and 5th toe. Results from the regression analysis
showed that toe deformities were weakly associated with
peak pressures in their pertaining forefoot regions. There
were no statistically significant differences in calcaneal
resting position and arch height between feet with and
without neuropathy. Callosities, toe deformity, calcaneal
alignment and arch height were previously identified as
distinct features in high risk diabetic patients with neu-
ropathy[1,49,54,55]. The severity of these clinical symp-
toms in the patients of this study are relatively mild. This
could be the explanation for the minor differences
between feet with and without neuropathy.
Table 4: Radiographic measurements
PNP- PNP+
Lateral radiograph Mean SD Min-Max Mean SD Min-Max
Sesamoid height (mm) 4.6 2.35 0.5–14 4.2 2.63 0–15
MT-5 head height (mm) 8.3 2.21 3.5–18 7.7 2.23 2–13.5
*MT-5 base height (mm) 15.4 3.91 4–26 14.1 4.50 5–24
**Navicular height (mm) 40.8 8.66 10–60 37.1 8.78 12.5–53
Calcaneal height (mm) 9.5 2.91 3–20 9.6 3.05 3–17
**Inferior calcaneal inclination (deg) 23.4 5.18 11–36.5 20.5 5.78 3–31
superior calcaneal inclination (deg) 21.7 5.52 8.5–35 20.7 7.12 2–35.5
*Chopart's joint angle (deg) 63.3 4.43 47–75.5 61.9 4.83 46–71.5
Navicular 1st cuneiform angle (deg) 64.0 5.20 49.5–76.5 64.7 4.47 56–77.5
**Lisfranc's joint angle (deg) 63.3 4.03 52.5–74 65.3 5.09 56–86
**MT-5 inclination (deg) 12.8 3.97 3.5–23.5 11.3 3.63 1–18.5
*MT-1 inclination (deg) 23.7 3.70 11.5–33 22.1 4.23 6.5–30
**Talar inclination (deg) 25.0 4.86 12.5–43 28.0 6.22 16–49.5
*1st PIP joint inclination (deg) 10.9 4.82 -3.5–25 8.8 7.01 -14–31.5
Anterior-posterior radiograph Mean SD Min-Max Mean SD Min-Max
*Hallux valgus (deg) 14.3 5.22 4–29 16.7 10.96 1.5–56.5
Intermetatarsal 1–5 angle (deg) 26.1 3.25 19–36.5 25.4 5.65 9.5–41
Intermetatarsal 1–2 angle (deg) 10.9 2.66 6–25 10.4 3.40 5–22
MTP-1 angle (deg) 14.3 5.22 4–29 16.7 10.96 1.5–56.5
Interphalangeal 1 angle (deg) 9.7 5.06 0–23.5 10.3 5.99 -10–26
Medial sesamoid X deviation (mm) 2.3 1.97 -2.5–7 1.8 3.32 -8–8.5
Medial sesamoid Y deviation (mm) 12.3 2.45 6–21 12.2 2.40 5.5–17.5
Lateral sesamoid X deviation (mm) 9.2 1.67 3.5–16 9.7 1.90 5–13.5
Lateral sesamoid Y deviation (mm) 15.4 2.45 7.5–21.5 16.0 3.11 8–24
Morton's index (mm) 1.5 2.94 -6–6.5 1.2 3.80 -5.5–17
MT-1 thickness (mm) 13.9 1.79 10.5–19.5 14.0 1.71 11–19
*MT-2 thickness (mm) 7.3 0.85 5.5–10 7.7 1.07 6–12.5
*MT- 3 thickness (mm) 6.4 0.71 5–8 6.8 1.11 5–12
MT-1 lenght (mm) 65.2 5.04 56–83.5 66.6 4.76 55–76.5
MT- 2 lenght (mm) 77.4 4.96 67.5–95.5 78.3 5.36 64.5–88
MT- 3 lenght (mm) 75.1 4.96 64.5–93 75.9 5.74 64–90
MT-4 lenght (mm) 73.3 4.93 61–88 74.3 5.32 54–83
MT- 5 lenght (mm) 72.9 5.24 61–84.5 73.3 5.02 57–82
PNP- versus PNP+ *p < 0.05 & **p < 0.005, PIP = proximal interphalangeal, deg = degreeB
M
C
 
E
n
d
o
c
r
i
n
e
 
D
i
s
o
r
d
e
r
s
 
2
0
0
8
,
 
8
:
1
6
h
t
t
p
:
/
/
w
w
w
.
b
i
o
m
e
d
c
e
n
t
r
a
l
.
c
o
m
/
1
4
7
2
-
6
8
2
3
/
8
/
1
6
P
a
g
e
 
8
 
o
f
 
1
4
(
p
a
g
e
 
n
u
m
b
e
r
 
n
o
t
 
f
o
r
 
c
i
t
a
t
i
o
n
 
p
u
r
p
o
s
e
s
)
Table 5: 
Clinical predictors Radiological predictors Comprehensive model
Region Variable RR 2 β SE Beta Variable RR 2 β SE Beta Variable RR 2 β SE Beta
Fore 
foot
model 0,37† 0,14 model 0,42† 0,18 model 0,51† 0,26
Intercept 3,863† 0,038 Intercept 4,039† 0,200 Intercept 3,605† 0,065
Valk
score
0,019† 0,004 0,35 MT-1
phalan
angle
0,019† 0,005 0,40 Valk
score
0,028† 0,006 0,31
Toe
deformity
sum
0,017† 0,076 0,29 Sesamoid
height
-0,043* 0,015 -0,20 Callus
sum
0,018* 0,006 0,21
Med
sesam Y
dev
-0,053* 0,015 -0,24 Moton's
index
0,027* 0,008 0,22
Deviation
hallux rx
0,010* 0,003 0,20
Hallux model 0,49† 0,24 model 0,38† 0,14 model 0.38† 0.14
Intercept 3,886† 0,149 Intercept -0,128† 0,708 Intercept -0,175† 0,704
Callus
formation
0,176† 0,036 0,32 Nav 1st
cuneifor
m
0,040† 0,010 0,28 Nav 1st
cuneiform
0,040† 0,010 0,28
Calcaneu
s varus
-0,266* 0,094 -0,19 MT-5
inclinatio
n
0,033* 0,013 0,18 MT-5
inclination
0,033* 0,013 0,18
Dorsal
flex ankle
-0,026* 0,008 0,22 Lat sesam
Y dev
0,046* 0,018 0,18 Med
sesam Y
dev
0,046* 0,018 0,18
Height
medial
arch
-0,151† 0,043 -0,23
MT-1 model 0,55† 0,30 model 0,42† 0,19 model 0,58† 0,34
Intercept 3,102† 0,058 Intercept 4,039† 0,200 Intercept 3,572† 0,170
Valk
score
0,025† 0,004 0,36 Sesamoid
height
-0,043† 0,015 -0,20 Valk
score
0,024† 0,004 0,35
1st toe
deformity
0,271* 0,095 0,18 Med
sesam Y
dev
-0,053* 0,015 -0,24 Callus
formation
0,133† 0,025 0,33
Callus
formation
0,135† 0,026 0,33 MT-1
phalan
angle
0,019* 0,005 -0,29 Deviation
hallux rx
0,012* 0,004 0,20
Med
sesam Y
dev
-0,051† 0,014 -0,24B
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MT-2 model 0,46† 0,21 Model 0,40† 0,16 model 0,50† 0,25
Intercept 3,483† 0,064 Intercept 2,656† 0,260 Intercept 2,607† 0,237
Callus
formation
0,126† 0,026 0,33 Devi
hallux rx
0,016† 0,004 0,29 Callus
formation
0,134† 0,025 0,35
2nd toe
deformity
0,111* 0,043 0,17 MT-2
thickness
0,118† 0,032 0,25 MT-2
thickness
0,133† 0,031 0,29
Valk 0,005* 0,002 0,19 Moton's
index
0,027* 0,009 0,20 2nd toe 
deformity
0,145* 0,042 0,23
MT-3 model 0,35† 0,12 Model 0,29† 0,09 model 0.40† 0.16
Intercept 3,251† 0,137 Intercept 3,531† 0,059 Intercept 3,220† 0,136
Callus
formation
0,102† 0,024 0,30 Moton's
index
Dev
0,025* 0,008 0,22 Callus
formation
0,098† 0,023 0,29
Body
Mass
Index
0,013* 0,005 0,20 hallux 0,010* 0,003 0,22 Body
Mass
Index
0,013* 0,004 0,18
Moton's
index
0,021* 0,008 0,20
MT-4 model 0,26† 0,07 Model 0,25† 0,06 model 0,35† 0,13
Intercept 3,263† 0,030 Intercept 2,030† 0,371 Intercept 2,026† 0,359
Callus
formation
0,095† 0,026 0,26 MT-4
length
0,018† 0,005 0,25 Callus
formation
0,091† 0,025 0,25
MT-4
length
0,017† 0,005 0,24
MT-5 model 0,40† 0,16 Model 0,47† 0,22 model 0,54† 0,29
Intercept 2,833† 0,056 1,448* 0,596 Intercept 1,933* 0,575
Callus
formation
0,215† 0,036 0,40 MT-5
length
0,033† 0,008 0,27 Callus
formation
0,181† 0,034 0,34
Moton's
index
-0,035* 0,013 -0,18 MT-5
length
0,023* 0,018 0,19
MT-5
head
height
-0,096† 0,019 -0,34 MT-5
head
height
-0,093† 0,008 -0,33
* = p < .01, † = p < .0001, MT = metatarsal, PIP = proximal interphalangeal, phalanx = phalangeal, nav = navicular, sum = summation of scores, med = medial, lat = lateral, dev = deviation
Table 5:  (Continued)BMC Endocrine Disorders 2008, 8:16 http://www.biomedcentral.com/1472-6823/8/16
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Relatively many differences were found for measurements
on lateral radiographs compared to anterior-posterior
radiographs. The soft tissue thickness under the head of
MT-5 is greater in patients without neuropathy, which
could be an explanation for the lower peak pressure in this
region compared to patients with neuropathy. A similar
relationship between soft tissue thickness and peak pres-
sure exists for MT-1 and was reported in previous stud-
ies[5,38,56].
Various radiological parameters indicate that neuropathic
feet have a lower arch structure than feet without neurop-
athy. Some parameters obtained from lateral and anterior-
posterior radiographs indicate similar classifications
found through clinical examination, such as arch height
and hallux alignment, although no statistically significant
differences were found.
Regression models
In general, the regression models with selected clinical
variables explained more variance in plantar pressure data
than the models with only radiological measures, suggest-
ing that clinical examination tells us more about plantar
pressure than information from radiographs.
For most regions, the prediction of plantar pressure
improved with the combination of radiological and clini-
cal data. The results show that clinical and radiological
measurements, either independently or in combination,
could explain only about 34 percent of the variance in
local bare foot peak pressure. In other words, with the
models constructed we have only 34 percent of useful
information from the clinical and radiological measure-
ments to make an prediction about the actual bare foot
peak pressure.
The Bland-Altman method was used for a visual impres-
sion of the individual difference between the predicted
and the actual pressure values. We evaluated the compre-
hensive regression model for the MT-1 region. The scat-
tered data along the wide interval of the horizontal axis in
figure 3 show a great variation. The considerable discrep-
ancy between the predicted and the actual peak pressure
indicating the inadequacy of the model, especially with
regard to the underestimation of high plantar pressure
values, i.e. > 700 kPa, for which an accurate estimation is
highly important.
In general, the previously reported regression models with
independent variables from clinical examination showed
similar results to our study. Ahroni et al. (1999) claimed
that high in-shoe plantar pressure in diabetic subjects
(1,017 feet) could be predicted through the use of clinical
variables, such as body mass, insulin use, Caucasian race,
male sex, plantar callus and diabetes duration[49]. Only
12 percent of the variation was explained. Although
Ahroni in his study found body mass to be identified as
the most important factor, Cavanagh et al. (1991) found
that body mass was a poor predictor[57].
Various predictive models relating plantar peak pressure
and structural variables obtained through imaging tech-
niques have been suggested)[38,47-49,58-62]. Cavanagh
et al. presented a model which explained approximately
40 percent of the variance in forefoot pressure during
walking with 3 to 4 static structural measurements from
foot radiographs of healthy subjects[38]. While we found
a similar result, 34 percent of explained variance is not
sufficient for prediction of plantar pressure.
Prediction models with the same or similar parameters applied to the 
present data set
Various regression models with demographically, clini-
cally and radiologically independent variables have been
suggested in the literature to estimate local plantar pres-
sure in patients with diabetes. Comparison of these mod-
els is difficult. Various methodological aspects are
different such as the population characteristics, the choice
of the plantar pressure parameters and how the data of the
independent variables were obtained. Despite these dif-
ferences, we constructed regression models with the same
or similar parameters and applied these models to our
data set.
We used radiological measures identical to those used by
Morag and Cavanagh (1999)[47] for the prediction of
barefoot peak pressure, but we could reach only 13 per-
cent explained variance. Cavanagh et al. (1997)[38] sug-
gested four radiological measures for peak pressure in the
MT-1 region. This model was also evaluated with our data
and analysed with the Bland-Altman method (figure 4).
Similarly modest results as for our own comprehensive
MT-1 model (figure 3) were found. Twenty-one percent
was the highest explained variance found, with the regres-
sion models formulated by Mueller et al.(2003)[48],
Ahroni et al. (1999)[49] and Payne et al. (2002)[50],
which implies that these models are not useful when
applied to the data of the present study.
This study was directed from a practical and ecological
research perspective, which means that the patients were
mostly screened according through common practice pro-
cedures: e.g. goniometry, blood pressure measurements,
etc. According to scientific criteria, these common practice
procedures often have inferior clinimetric qualities and
are likely to contribute to inherent variability. Maybe
other clinical or radiological measurements are less prone
to inherent variability and may be stronger predictors forBMC Endocrine Disorders 2008, 8:16 http://www.biomedcentral.com/1472-6823/8/16
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local peak pressure. We studied diabetic patients without
foot complications such as severe deformities and gait
abnormalities. Some of the results might well be different
in patients with these complications of diabetes. Never-
theless, we think it is important to identify patients with
elevated plantar pressures in their early stage of disease in
order to take appropriate preventive measures. The screen-
ing of these kind of patients is typically done in peripheral
care centres where there is no radiological facility or
plantar pressures equipment are available.
Clinical signs are potentially more cost-effective than
sophisticated diagnostic tests which are less feasible in
community settings. However, the results form this study
confirm the conclusions of a previous study which
showed that identification of locations with elevated
plantar pressure is not possible through physical examina-
tion[63]. The use of radiological measures does not pro-
vide a better prediction of local barefoot peak pressure.
There is a clear need for further research to address these
clinical uncertainties. The use of quantitative plantar pres-
sure measurement is therefore advocated for diabetic foot
care.
Conclusion
Peak pressures were higher in patients with neuropathy
than in patients without neuropathy, although feet were
quite similar as far as clinical and radiological evaluations
is concerned. At best, clinical and radiological measure-
ments could explain about 34 percent of the variance in
local barefoot peak pressure in this population of diabetic
patients. The prediction models constructed with regres-
sion modeling were not useful in clinical practice, because
of considerable discrepancies between the predicted and
the actual peak pressure values. Identification of elevated
plantar pressure without equipment for quantification of
plantar pressure is inadequate. This points toward the
The difference between the observed and predicted peak pressure plotted against the mean (kPa), based on the comprehen- sive regression model for MT-1 region Figure 3
The difference between the observed and predicted peak pressure plotted against the mean (kPa), based on 
the comprehensive regression model for MT-1 region. Comprehensive model (r2 34%). Independent variables: Valk 
score, Deviation hallux x-ray, Callus formation, Medial sesamoid Y-axis deviation.
Difference against mean of observed & predicted peak pressure 
(kPa) for metatarsal one region (mt-1)
-800
-700
-600
-500
-400
-300
-200
-100
0
100
200
300
400
500
600
700
800
0 50 100 150 200 250 300 350 400 450 500 550 600 650 700 750 800 850 900
(Peak Pressure mt-1 + predicted value)/2
d
i
f
f
e
r
e
n
c
e
 
P
e
a
k
 
P
r
e
s
s
u
r
e
 
m
t
-
1
 
m
i
n
u
s
 
p
r
e
d
i
c
t
e
d
 
v
a
l
u
e
1 SD
2 SD
2 SD
1 SDBMC Endocrine Disorders 2008, 8:16 http://www.biomedcentral.com/1472-6823/8/16
Page 12 of 14
(page number not for citation purposes)
merit of quantitative plantar pressure measurement for
diabetic foot screening.
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